BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1668 related articles for article (PubMed ID: 30351060)

  • 21. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
    Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
    Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
    Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
    Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
    Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
    Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan-based DDSs for pH/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity.
    Xie P; Liu P
    Carbohydr Polym; 2022 Jan; 275():118760. PubMed ID: 34742449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method.
    Tian J; Xu S; Deng H; Song X; Li X; Chen J; Cao F; Li B
    Int J Pharm; 2017 Jan; 517(1-2):25-34. PubMed ID: 27845214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface charge effect on mucoadhesion of chitosan based nanogels for local anti-colorectal cancer drug delivery.
    Feng C; Li J; Kong M; Liu Y; Cheng XJ; Li Y; Park HJ; Chen XG
    Colloids Surf B Biointerfaces; 2015 Apr; 128():439-447. PubMed ID: 25769283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe
    Gerami SE; Pourmadadi M; Fatoorehchi H; Yazdian F; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Mar; 173():409-420. PubMed ID: 33454326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy.
    Fu B; Dang M; Tao J; Li Y; Tang Y
    J Colloid Interface Sci; 2020 Jun; 570():197-204. PubMed ID: 32151829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers.
    Hu Y; Ding Y; Ding D; Sun M; Zhang L; Jiang X; Yang C
    Biomacromolecules; 2007 Apr; 8(4):1069-76. PubMed ID: 17326676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
    Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
    Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimuli-responsive lipid nanotubes in gel formulations for the delivery of doxorubicin.
    Ilbasmis-Tamer S; Unsal H; Tugcu-Demiroz F; Kalaycioglu GD; Degim IT; Aydogan N
    Colloids Surf B Biointerfaces; 2016 Jul; 143():406-414. PubMed ID: 27037777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy.
    Jia Q; Li Z; Guo C; Huang X; Song Y; Zhou N; Wang M; Zhang Z; He L; Du M
    Nanoscale; 2019 Nov; 11(43):20956-20967. PubMed ID: 31660562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
    Javanbakht S; Pooresmaeil M; Namazi H
    Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
    Chen CK; Wang Q; Jones CH; Yu Y; Zhang H; Law WC; Lai CK; Zeng Q; Prasad PN; Pfeifer BA; Cheng C
    Langmuir; 2014 Apr; 30(14):4111-9. PubMed ID: 24665861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
    Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
    Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.